Net Worth Advisory Group’s Novo Nordisk NVO Stock Holding History

Net Worth Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$251K	Buy	6,705 +489	+8%	+$22.5K	0.06%	345
2026 Q2	$298K	Sell	6,216 -853	-12%	-$36.6K	0.08%	287
2026 Q1	$260K	Buy	7,069 +2,628	+59%	+$125K	0.05%	347
2025 Q4	$226K	Sell	4,441 -1,816	-29%	-$92.9K	0.05%	405
2025 Q3	$347K	Sell	6,257 -1,128	-15%	-$66K	0.1%	230
2025 Q2	$510K	Buy	7,385 +1,605	+28%	+$109K	0.11%	191
2025 Q1	$401K	Sell	5,780 -31	-0.5%	-$2.56K	0.13%	188
2024 Q4	$500K	Sell	5,811 -243	-4%	-$26.3K	0.15%	175
2024 Q3	$721K	Buy	+6,054	New	+$807K	0.21%	113

Other funds holding NVO

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.71B AUM 69.59% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Net Worth Advisory Group's NVO Position: Q3 2026 in Review

Net Worth Advisory Group increased its Novo Nordisk (NVO) stake by 7.9% in Q3 2026, buying an estimated $22.5K and bringing the position to 6,705 shares worth $251K. The position accounts for 0.06% of the portfolio, ranked #345.

Net Worth Advisory Group first reported a position in NVO in Q3 2024 and has held it in 9 quarters since. The position peaked at $721K in Q3 2024. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Net Worth Advisory Group held 6,705 shares of Novo Nordisk worth $251K as of Q3 2026.
Net Worth Advisory Group bought 489 Novo Nordisk shares in Q3 2026, an estimated $22.5K.
Novo Nordisk made up 0.06% of Net Worth Advisory Group's portfolio in Q3 2026, its #345 holding.
Net Worth Advisory Group first reported a position in Novo Nordisk in Q3 2024 and has held it in 9 quarters since.
Net Worth Advisory Group's Novo Nordisk position peaked at $721K in Q3 2024.
1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Net Worth Advisory Group's 13F filing for Q3 2026, filed 20 Oct 2026.